Global and United States Asthma Immunotherapies Market Report & Forecast 2023-2028

Report ID: 1825804 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Asthma Immunotherapies Revenue in Asthma Immunotherapies Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Asthma Immunotherapies Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Asthma Immunotherapies Market Size for the Year 2017-2028
        1.2.2 Global Asthma Immunotherapies Market Size for the Year 2017-2028
    1.3 Asthma Immunotherapies Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Asthma Immunotherapies in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Asthma Immunotherapies Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Asthma Immunotherapies Market Dynamics
        1.4.1 Asthma Immunotherapies Industry Trends
        1.4.2 Asthma Immunotherapies Market Drivers
        1.4.3 Asthma Immunotherapies Market Challenges
        1.4.4 Asthma Immunotherapies Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Asthma Immunotherapies by Type
    2.1 Asthma Immunotherapies Market Segment by Type
        2.1.1 Subcutaneous Immunotherapy
        2.1.2 Sublingual Immunotherapy
    2.2 Global Asthma Immunotherapies Market Size by Type (2017, 2022 & 2028)
    2.3 Global Asthma Immunotherapies Market Size by Type (2017-2028)
    2.4 United States Asthma Immunotherapies Market Size by Type (2017, 2022 & 2028)
    2.5 United States Asthma Immunotherapies Market Size by Type (2017-2028)
3 Asthma Immunotherapies by Application
    3.1 Asthma Immunotherapies Market Segment by Application
        3.1.1 Hospital Pharmacies
        3.1.2 Online Pharmacies
        3.1.3 Retail Pharmacies
    3.2 Global Asthma Immunotherapies Market Size by Application (2017, 2022 & 2028)
    3.3 Global Asthma Immunotherapies Market Size by Application (2017-2028)
    3.4 United States Asthma Immunotherapies Market Size by Application (2017, 2022 & 2028)
    3.5 United States Asthma Immunotherapies Market Size by Application (2017-2028)
4 Global Asthma Immunotherapies Competitor Landscape by Company
    4.1 Global Asthma Immunotherapies Market Size by Company
        4.1.1 Top Global Asthma Immunotherapies Companies Ranked by Revenue (2021)
        4.1.2 Global Asthma Immunotherapies Revenue by Player (2017-2022)
    4.2 Global Asthma Immunotherapies Concentration Ratio (CR)
        4.2.1 Asthma Immunotherapies Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Asthma Immunotherapies in 2021
        4.2.3 Global Asthma Immunotherapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Asthma Immunotherapies Headquarters, Revenue in Asthma Immunotherapies Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Asthma Immunotherapies Headquarters and Area Served
        4.3.2 Global Asthma Immunotherapies Companies Revenue in Asthma Immunotherapies Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Asthma Immunotherapies Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Asthma Immunotherapies Market Size by Company
        4.5.1 Top Asthma Immunotherapies Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Asthma Immunotherapies Revenue by Players (2020, 2021 & 2022)
5 Global Asthma Immunotherapies Market Size by Region
    5.1 Global Asthma Immunotherapies Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Asthma Immunotherapies Market Size by Region (2017-2028)
        5.2.1 Global Asthma Immunotherapies Market Size by Region: 2017-2022
        5.2.2 Global Asthma Immunotherapies Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Asthma Immunotherapies Market Size YoY Growth 2017-2028
        6.1.2 North America Asthma Immunotherapies Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Asthma Immunotherapies Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Asthma Immunotherapies Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Asthma Immunotherapies Market Size YoY Growth 2017-2028
        6.3.2 Europe Asthma Immunotherapies Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Asthma Immunotherapies Market Size YoY Growth 2017-2028
        6.4.2 Latin America Asthma Immunotherapies Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Asthma Immunotherapies Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Asthma Immunotherapies Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Anergis
        7.1.1 Anergis Company Details
        7.1.2 Anergis Business Overview
        7.1.3 Anergis Asthma Immunotherapies Introduction
        7.1.4 Anergis Revenue in Asthma Immunotherapies Business (2017-2022)
        7.1.5 Anergis Recent Development
    7.2 HAL Allergy Group
        7.2.1 HAL Allergy Group Company Details
        7.2.2 HAL Allergy Group Business Overview
        7.2.3 HAL Allergy Group Asthma Immunotherapies Introduction
        7.2.4 HAL Allergy Group Revenue in Asthma Immunotherapies Business (2017-2022)
        7.2.5 HAL Allergy Group Recent Development
    7.3 Merck
        7.3.1 Merck Company Details
        7.3.2 Merck Business Overview
        7.3.3 Merck Asthma Immunotherapies Introduction
        7.3.4 Merck Revenue in Asthma Immunotherapies Business (2017-2022)
        7.3.5 Merck Recent Development
    7.4 ALK-Abello
        7.4.1 ALK-Abello Company Details
        7.4.2 ALK-Abello Business Overview
        7.4.3 ALK-Abello Asthma Immunotherapies Introduction
        7.4.4 ALK-Abello Revenue in Asthma Immunotherapies Business (2017-2022)
        7.4.5 ALK-Abello Recent Development
    7.5 Stallergenes Greer
        7.5.1 Stallergenes Greer Company Details
        7.5.2 Stallergenes Greer Business Overview
        7.5.3 Stallergenes Greer Asthma Immunotherapies Introduction
        7.5.4 Stallergenes Greer Revenue in Asthma Immunotherapies Business (2017-2022)
        7.5.5 Stallergenes Greer Recent Development
    7.6 Laboratorios LETI
        7.6.1 Laboratorios LETI Company Details
        7.6.2 Laboratorios LETI Business Overview
        7.6.3 Laboratorios LETI Asthma Immunotherapies Introduction
        7.6.4 Laboratorios LETI Revenue in Asthma Immunotherapies Business (2017-2022)
        7.6.5 Laboratorios LETI Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Asthma Immunotherapies Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Asthma Immunotherapies Market Trends
    Table 3. Asthma Immunotherapies Market Drivers
    Table 4. Asthma Immunotherapies Market Challenges
    Table 5. Asthma Immunotherapies Market Restraints
    Table 6. Global Asthma Immunotherapies Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Asthma Immunotherapies Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Asthma Immunotherapies Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Asthma Immunotherapies Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Asthma Immunotherapies Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Asthma Immunotherapies Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Asthma Immunotherapies Revenue Share by Player, 2017-2022
    Table 13. Global Asthma Immunotherapies Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Asthma Immunotherapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Immunotherapies as of 2021)
    Table 15. Top Players of Asthma Immunotherapies in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Asthma Immunotherapies Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Asthma Immunotherapies Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Asthma Immunotherapies Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Asthma Immunotherapies Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Asthma Immunotherapies Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Asthma Immunotherapies Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Asthma Immunotherapies Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Asthma Immunotherapies Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Asthma Immunotherapies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Asthma Immunotherapies Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Asthma Immunotherapies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Asthma Immunotherapies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Asthma Immunotherapies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Anergis Company Details
    Table 31. Anergis Business Overview
    Table 32. Anergis Asthma Immunotherapies Product
    Table 33. Anergis Revenue in Asthma Immunotherapies Business (2017-2022) & (US$ Million)
    Table 34. Anergis Recent Development
    Table 35. HAL Allergy Group Company Details
    Table 36. HAL Allergy Group Business Overview
    Table 37. HAL Allergy Group Asthma Immunotherapies Product
    Table 38. HAL Allergy Group Revenue in Asthma Immunotherapies Business (2017-2022) & (US$ Million)
    Table 39. HAL Allergy Group Recent Development
    Table 40. Merck Company Details
    Table 41. Merck Business Overview
    Table 42. Merck Asthma Immunotherapies Product
    Table 43. Merck Revenue in Asthma Immunotherapies Business (2017-2022) & (US$ Million)
    Table 44. Merck Recent Development
    Table 45. ALK-Abello Company Details
    Table 46. ALK-Abello Business Overview
    Table 47. ALK-Abello Asthma Immunotherapies Product
    Table 48. ALK-Abello Revenue in Asthma Immunotherapies Business (2017-2022) & (US$ Million)
    Table 49. ALK-Abello Recent Development
    Table 50. Stallergenes Greer Company Details
    Table 51. Stallergenes Greer Business Overview
    Table 52. Stallergenes Greer Asthma Immunotherapies Product
    Table 53. Stallergenes Greer Revenue in Asthma Immunotherapies Business (2017-2022) & (US$ Million)
    Table 54. Stallergenes Greer Recent Development
    Table 55. Laboratorios LETI Company Details
    Table 56. Laboratorios LETI Business Overview
    Table 57. Laboratorios LETI Asthma Immunotherapies Product
    Table 58. Laboratorios LETI Revenue in Asthma Immunotherapies Business (2017-2022) & (US$ Million)
    Table 59. Laboratorios LETI Recent Development
    Table 60. Research Programs/Design for This Report
    Table 61. Key Data Information from Secondary Sources
    Table 62. Key Data Information from Primary Sources
List of Figures
    Figure 1. Asthma Immunotherapies Product Picture
    Figure 2. Global Asthma Immunotherapies Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Asthma Immunotherapies Market Size 2017-2028 (US$ Million)
    Figure 4. United States Asthma Immunotherapies Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Asthma Immunotherapies Market Size 2017-2028 (US$ Million)
    Figure 6. United States Asthma Immunotherapies Market Share in Global 2017-2028
    Figure 7. Asthma Immunotherapies Report Years Considered
    Figure 8. Product Picture of Subcutaneous Immunotherapy
    Figure 9. Product Picture of Sublingual Immunotherapy
    Figure 10. Global Asthma Immunotherapies Market Share by Type in 2022 & 2028
    Figure 11. Global Asthma Immunotherapies Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Asthma Immunotherapies Market Share by Type (2017-2028)
    Figure 13. United States Asthma Immunotherapies Market Share by Type in 2022 & 2028
    Figure 14. United States Asthma Immunotherapies Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Asthma Immunotherapies Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospital Pharmacies
    Figure 17. Product Picture of Online Pharmacies
    Figure 18. Product Picture of Retail Pharmacies
    Figure 19. Global Asthma Immunotherapies Market Share by Application in 2022 & 2028
    Figure 20. Global Asthma Immunotherapies Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Asthma Immunotherapies Market Share by Application (2017-2028)
    Figure 22. United States Asthma Immunotherapies Market Share by Application in 2022 & 2028
    Figure 23. United States Asthma Immunotherapies Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Asthma Immunotherapies Market Share by Application (2017-2028)
    Figure 25. North America Asthma Immunotherapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Asthma Immunotherapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Asthma Immunotherapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Asthma Immunotherapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Asthma Immunotherapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Asthma Immunotherapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Anergis Revenue Growth Rate in Asthma Immunotherapies Business (2017-2022)
    Figure 54. HAL Allergy Group Revenue Growth Rate in Asthma Immunotherapies Business (2017-2022)
    Figure 55. Merck Revenue Growth Rate in Asthma Immunotherapies Business (2017-2022)
    Figure 56. ALK-Abello Revenue Growth Rate in Asthma Immunotherapies Business (2017-2022)
    Figure 57. Stallergenes Greer Revenue Growth Rate in Asthma Immunotherapies Business (2017-2022)
    Figure 58. Laboratorios LETI Revenue Growth Rate in Asthma Immunotherapies Business (2017-2022)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Anergis
HAL Allergy Group
Merck
ALK-Abello
Stallergenes Greer
Laboratorios LETI
Frequently Asked Questions
Asthma Immunotherapies report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Asthma Immunotherapies report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Asthma Immunotherapies report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports